Metraipolis › archive › dc_41dcbe23802a

The evaluating prescription opioid changes in veterans (EPOCH) study: Design, survey response, and baseline characteristics — Europe PMC PMID:32320421

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/32320421
DOI
10.1371/journal.pone.0230751
License (as archived)
CC0-1.0
Archived
2026-11-08T23:04:25.620Z
SHA-256 of the archived text
13df9300a766ee3b7db4c404b3c085259b281f13c2129626d83d3f7e01c7c57c
Stable URL of this page
https://metraipolis.com/documento/dc_41dcbe23802a

How to cite

The evaluating prescription opioid changes in veterans (EPOCH) study: Design, survey response, and baseline characteristics — Europe PMC PMID:32320421 — Europe PMC (en), https://europepmc.org/article/MED/32320421 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_41dcbe23802a (Metraipolis archive dc_41dcbe23802a, sha256 13df9300a766ee3b7db4c404b3c085259b281f13c2129626d83d3f7e01c7c57c)
BibTeX
@misc{dc41dcbe23802a,
  title = {The evaluating prescription opioid changes in veterans (EPOCH) study: Design, survey response, and baseline characteristics — Europe PMC PMID:32320421},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/32320421},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_41dcbe23802a; sha256 13df9300a766ee3b7db4c404b3c085259b281f13c2129626d83d3f7e01c7c57c},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/32320421. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

In the United States (US), long-term opioid therapy has been commonly prescribed for chronic pain. Since recognition of the opioid overdose epidemic, clinical practice guidelines have recommended tapering long-term opioids to reduced doses or discontinuation. The Effects of Prescription Opioid Changes for veterans (EPOCH) study is a national population-based prospective observational study of US Veterans Health Administration primary care patients designed to assess effects of evolving opioid prescribing practice on patients treated with long-term opioids for chronic pain. A stratified random sampling design was used to identify a survey sample from the target population of patients treated with opioid analgesics for ≥ 6 months. Demographic, diagnostic, visit, and pharmacy dispensing data were extracted from existing datasets. A 2016 mixed-mode mail and telephone survey collected patient-reported data, including the main patient-reported outcomes of pain-related function (Brief Pain Inventory interference; BPI-I scores 0-10, higher scores = worse) and health-related quality of life. Data on survey participants and non-participants were analyzed to assess potential nonresponse bias. Weights were used to account for design. Linear regression models were used to assess cross-sectional associations of opioid treatment with patient-reported measures. Of 14,160 patients contacted, 9253 (65.4%) completed the survey. Participants were older than non-participants (63.9 ± 10.6 vs. 59.6 ± 13.0 years). The mean number of bothersome pain locations was 6.8 (SE 0.04). Effectiveness of pain treatment and quality of pain care were rated fair or poor by 56.1% and 45.3%, respectively. The opioid daily dosage range was 1.6 to 1038.2 mg, with mean = 50.6 mg (SE 1.1) and median = 30.9 mg (IQR 40.7). Among the 73.2% of patients who did not receive long-acting opioids, the mean daily dosage was 30.4 mg (SE 0.6) and mean BPI-I was 6.4 (SE 00.4). Among patients who received long-acting opioids, the mean daily dosage was 106.2 mg (SE 2.8) and mean BPI-I was 6.8 (SE 0.07). Higher daily dosage was associated with worse pain-related function and quality of life among patients without long-acting opioids, but not among patients with long-acting opioids. Future analyses will use follow-up data to examine effects of opioid dose reduction and discontinuation on patient outcomes.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2020 (prima pubblicazione 2020-04-22).
Identificativi: PMID 32320421 · PMCID PMC7176145 · DOI 10.1371/journal.pone.0230751.
Descrittori MeSH principali: Analgesics, Opioid; Surveys and Questionnaires.
Pagina: https://europepmc.org/article/MED/32320421 — https://doi.org/10.1371/journal.pone.0230751. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-08T23:00:53.090Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.